A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illnessVicky Gunther, Wellington Sun, Robert Putnak et al.|Vaccine|2011Cited by 111
A Phase II, Randomized, Safety and Immunogenicity Study of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy AdultsStephen J. Thomas, Bruce L. Innis, Wellington Sun et al.|American Journal of Tropical Medicine and Hygiene|2012Cited by 97
A Phase II, Randomized, Safety and Immunogenicity Trial of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Children and Adults Living in Puerto RicoKristen M. Bauer, Bruce L. Innis, Ines O. Esquilin et al.|American Journal of Tropical Medicine and Hygiene|2015Cited by 35
A Phase 1/2 Trial of a Tetravalent Live-Attenuated Dengue Vaccine in Flavivirus-Native Thai InfantsWatanaveeradej, David W. Vaughn, Angkool Kerdpanich et al.|Unknown|2006Cited by 0